]>
IRCT20190730044382N1 IRCT 2019-08-27 Gonabad University of Medical Sciences The effect of vitamin B6 on anemia The Comparison of hemoglobin and hematocrit in two groups receiving vitamin B6 and iron with iron in women with iron deficiency anemia referred to health and medical centers of Gonabad city in 1398 2019-08-04 anticipated 66 Complete https://irct.ir/trial/41212 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 3 Iron deficiency anemia. Intervention 1: Intervention group will be given 100 mg iron tablets daily (ferrous sulfate) and 80 mg vitamin B6 tablets (pyridoxine hydrochloride manufactured by Iran Hormone Company) for one month. Intervention 2: Control group: 100 mg iron tablets (ferrous sulfate) daily will be given for one month. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Asma Salar
No.7, Gaem Ave, Gonabad Town
Gonabad Iran (Islamic Republic of) 9691145435 +98 51 5728 8961 salar.a.stu@gmu.ac.ir Gonabad University of Medical Sciences scientific Asma Salar
No.7, Gaem Ave, Gonabad Town
Gonabad Iran (Islamic Republic of) 9691145435 +98 51 5728 8961 salar.a.stu@gmu.ac.ir Gonabad University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) MCV <80fl and MCH <and MCHC <33g /dl and ferritin <12mcg / l HB = 8-12gr / dl No history of gastrointestinal bleeding and gastrointestinal surgery and diseases associated with malabsorption including celiac based on patient statement and records No drug and hemoglobin-increasing agents in the last month (blood transfusion, intravenous administration of iron, iron tablets and erythropoietin in the last one month) Lack of any hereditary anemia (including thalassemia and tuberculosis anemia ... based on patient's statement) Lack of chronic disease based on history Not taking other medicines (based on patient's statement or accompanying medication) Not taking supplements, including multivitamins and calcium, on a patient statement No smoking No alcohol or coffee utilization No pregnant no limit no limit Female cutt or change medication Not taking iron tablets in the control group and the case even once Not taking vitamin B6 in the case group for even one time Not willing to participate in the study further D50.9 Iron deficiency anemia, unspecified Treatment - Drugs Treatment - Drugs Intervention group will be given 100 mg iron tablets daily (ferrous sulfate) and 80 mg vitamin B6 tablets (pyridoxine hydrochloride manufactured by Iran Hormone Company) for one month. Control group: 100 mg iron tablets (ferrous sulfate) daily will be given for one month. Percentage of people with increased hemoglobin. Timepoint: At baseline and 30 days after intervention. Method of measurement: To check the complete blood cell count, all women will receive 2 cc of blood in an EDTA vacuum tube and will be tested with the BC5800 CBC manufacturing in 2015. Percentage of people with increased hematocrit. Timepoint: At baseline and 30 days after intervention. Method of measurement: To check the complete blood cell count, all women will receive 2 cc of blood in an EDTA vacuum tube and will be tested with the BC5800 CBC manufacturing in 2015. Gonabad University of Medical Sciences Approved 2019-07-27 Ethics committee of Gonabad University of Medical Sciences Gonabad University of Medical Sciences, Santo Road Asian Margin Gonabad Razavi Khorasan Iran (Islamic Republic of)